Entrada Therapeutics, Inc. (TRDA) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.04M | -67.0% |
| 2024 | $3.16M | -43.7% |
| 2023 | $5.61M | +94.5% |
| 2022 | $2.89M | -37.0% |
| 2021 | $4.58M | +97.6% |
| 2020 | $2.32M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.04M | -67.0% |
| 2024 | $3.16M | -43.7% |
| 2023 | $5.61M | +94.5% |
| 2022 | $2.89M | -37.0% |
| 2021 | $4.58M | +97.6% |
| 2020 | $2.32M | — |